Form 4: Karen May Receives Solventum RSU Grant

Director Karen May was granted 3,300 restricted stock units in Solventum Corp, vesting in May 2027.

Summary

• Director Karen J. May received a grant of 3,300 Restricted Stock Units (RSUs) on May 15, 2026.
• Each RSU represents a contingent right to receive one share of Solventum Corp common stock upon settlement.
• The grant is subject to a one-year vesting period, with full vesting scheduled for May 15, 2027, contingent upon continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.

Future Outlook

The RSUs are scheduled to vest on May 15, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is consistent with standard compensation practices for publicly traded companies in the healthcare and technology sectors.

Stakeholder Impact

• Minimal impact on shareholders; represents standard director compensation.

Next Steps

• Vesting of the 3,300 RSUs on May 15, 2027.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Director Compensation, Restricted Stock Units